Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
It is essential to improve therapies for controlling excessive bleeding in patients with haemorrhagic disorders. As activated blood platelets mediate the primary response to vascular injury, we hypothesize that storage of coagulation Factor VIII within platelets may provide a locally inducible treatment to maintain haemostasis for haemophilia A. Here we show that haematopoietic stem cell gene therapy can prevent the occurrence of severe bleeding episodes in dogs with haemophilia A for at least 2.5 years after transplantation. We employ a clinically relevant strategy based on a lentiviral vector encoding the ITGA2B gene promoter, which drives platelet-specific expression of human FVIII permitting storage and release of FVIII from activated platelets. One animal receives a hybrid molecule of FVIII fused to the von Willebrand Factor propeptide-D2 domain that traffics FVIII more effectively into α-granules. The absence of inhibitory antibodies to platelet-derived FVIII indicates that this approach may have benefit in patients who reject FVIII replacement therapies. Thus, platelet FVIII may provide effective long-term control of bleeding in patients with haemophilia A.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
Langdell, R. D., Wagner, R. H., & Brinkhous, K. M. (1953) · PubMed · Cited by 852
Sanders, J., Hawley, J., Levy, W., Gooley, T., Buckner, C., Deeg, H., Doney, K., Storb, R., Sullivan, K., Witherspoon, R., et al. (1996) · Blood · doi:10.1182/blood.v87.7.3045.bloodjournal8773045 · Cited by 722
Wiznerowicz, M., & Trono, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8957-8951.2003 · Cited by 701
Kitazawa, T., Igawa, T., Sampei, Z., Muto, A., Kojima, T., Soeda, T., Yoshihashi, K., Okuyama-Nishida, Y., Saito, H., Tsunoda, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2942 · Cited by 507
Megakaryocytic and erythrocytic lineages share specific transcription factors
Romeo, P.-H., Prandini, M.-H., Joulin, V., Mignotte, V., Prenant, M., Vainchenker, W., Marguerie, G., & Uzan, G. (1990) · Nature · doi:10.1038/344447a0 · Cited by 418
Specific roles for platelet surface glycoproteins in platelet function
NURDEN, A. T., & CAEN, J. P. (1975) · Nature · doi:10.1038/255720a0 · Cited by 405
Self-citationSynthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells.
Kaufman, R. J., Wasley, L. C., & Dorner, A. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68793-9 · Cited by 380
Berntorp, E., & Shapiro, A. D. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61139-2 · Cited by 335
Beyond Clotting: The Powers of Platelets
Leslie, M. (2010) · Science · doi:10.1126/science.328.5978.562 · Cited by 332
Cited by
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
Murine coagulation factor VIII is synthesized in endothelial cells
Everett, L. A., Cleuren, A. C. A., Khoriaty, R. N., & Ginsburg, D. (2014) · Blood · doi:10.1182/blood-2014-02-554501 · Cited by 190
Adeno-Associated Virus Gene Therapy for Hemophilia
Samelson‐Jones, B. J., & George, L. A. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-043021-033013 · Cited by 150
Novel approaches to hemophilia therapy: successes and challenges
Arruda, V. R., Doshi, B. S., & Samelson‐Jones, B. J. (2017) · Blood · doi:10.1182/blood-2017-08-742312 · Cited by 124
von Willebrand factor propeptide: biology and clinical utility
Haberichter, S. L. (2015) · Blood · doi:10.1182/blood-2015-04-512731 · Cited by 99
Self-citation
Metadata
- Authors
- Du, L. M., Nurden, P., Nurden, A. T., Nichols, T. C., Bellinger, D. A., Jensen, E. S., Haberichter, S. L., Merricks, E., Raymer, R. A., Fang, J., Koukouritaki, S. B., Jacobi, P. M., Hawkins, T. B., Cornetta, K., Shi, Q., & Wilcox, D. A.
- Affiliations
- Children's Hospital of Wisconsin (US)
- Electrophysiology and Heart Modeling Institute (FR)
- University of North Carolina at Chapel Hill (US)
- Versiti Blood Center of Wisconsin (US)
- Indiana University Indianapolis (US)
- Corresponding author
- Wilcox, David A.
- ORCID
- Venue
- Nature Communications
- Published
- 2013-11-19
- Volume
- 4
- Issue
- 1
- Pages
- 2773-2773
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3868233
- OpenAlex
- W2039928766
- Cited by
- 119
- References
- 59
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 11 · 2022: 11 · 2021: 9 · 2020: 9 · 2019: 6 · 2018: 9 · 2017: 7 · 2016: 14 · 2015: 21 · 2014: 11 · 2013: 2
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- UNC Libraries
- Funders
- American Heart Association
- Medical College of Wisconsin
- Children’s Hospital of Wisconsin Research Institute
- Children's Hospital Foundation
- Agence Nationale de la Recherche (ANR-08-GENO-028-03)
- Institut National de la Santé et de la Recherche Médicale (ANR-08-GENO-028-03)
- National Institutes of Health (HL-68138, HL63098)
- University of North Carolina at Chapel Hill
- National Heart, Lung, and Blood Institute (HL-102035, P40HL116242, HL 68138, R24HL063098, R01HL068138, HL-63 098, R01HL102035)
- Topics
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- hemophilia A, factor VIII, hemostasis, lentiviral vectors, platelet alpha-granules, factor VIII inhibitors, dogs, hemorrhage control
- MeSH terms
- Animals, Blood Platelets, Dog Diseases, Dogs, Factor VIII, Gene Expression Regulation, Hemophilia A, Hemostasis, Humans, Genetic Therapy, Integrin alpha2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A. https://app.cochat.ai/papers/10.1038/ncomms3773
- The paper
- Du, L. M., Nurden, P., Nurden, A. T., Nichols, T. C., Bellinger, D. A., Jensen, E. S., Haberichter, S. L., Merricks, E., Raymer, R. A., Fang, J., Koukouritaki, S. B., Jacobi, P. M., Hawkins, T. B., Cornetta, K., Shi, Q., & Wilcox, D. A. (2013). Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A. Nature Communications. https://doi.org/10.1038/ncomms3773
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.